Actively Recruiting
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Led by M.D. Anderson Cancer Center · Updated on 2026-03-11
50
Participants Needed
1
Research Sites
280 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
To track the outcomes of patients who have been treated with RFA and its long-term effectiveness, and to learn more about the quality of life of patients who have received RFA in this study.
CONDITIONS
Official Title
Radiofrequency Ablation for Management of Benign/Indeterminate Thyroid Nodules and Low Risk Papillary Thyroid Cancers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Scheduled for ultrasound-guided radiofrequency ablation for benign thyroid nodules, indeterminate nodules, low-risk differentiated thyroid cancer, or recurrent papillary thyroid cancer
- Age over 18 years
- Not a candidate for surgery or has declined surgery
- Capable and willing to provide written informed consent
- Diagnosed with biopsy-proven benign thyroid nodules causing symptoms requesting treatment, indeterminate nodules (AUS or follicular neoplasm), papillary thyroid carcinoma without metastasis, or locally recurrent thyroid cancer smaller than 2 cm
You will not qualify if you...
- Considered unsuitable for radiofrequency ablation by the treating physician
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
MD Anderson Cancer Center
Houston, Texas, United States, 77030
Actively Recruiting
Research Team
V
Victoria E Banuchi, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here